Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: Links to HIV-1 dementia

Radhika Suryadevara, Spring Holter, Kathleen Borgmann, Raisa Persidsky, Christine Labenz-Zink, Yuri Persidsky, Howard Eliot Gendelman, Li Wu, Anuja Ghorpade

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

The neuropathogenesis of HIV-1-associated dementia (HAD) revolves around the secretion of toxic molecules from infected and immune-competent mononuclear phagocytes. Astrocyte activation occurs in parallel but limited insights are available for its role in neurotoxicity and cognitive dysfunction. One means in which astrocytes may affect disease is through their production of tissue inhibitors of metalloproteinases (TIMPs). TIMPs are regulators of matrix metalloproteinases, enzymes that affect blood-brain barrier integrity through altering the extracellular matrix. We hypothesized that in response to injury and inflammation in HAD, astrocytes regulate the production of TIMP-1, the inducible type of TIMP that is important in inflammation. To address astrocyte-mediated TIMP-1 regulation in HAD, we evaluated the responses of primary human to IL-1β and HIV-1. TIMP-1 levels in plasma, CSF, and brain tissue of control, HIV-1 infected patients without cognitive impairment, and HAD patients were also studied. Our data show that an upregulation of TIMP-1 results from astrocytes acutely activated with IL-1β. In contrast, CSF and brain tissue samples from HAD patients showed reduced TIMP-1 levels compared to seronegative controls. MMP-2 levels in brains showed the opposite. Consistent with this, prolonged activation of astrocytes led to a reduction in TIMP-1 and MMP-2, but a sustained elevation in MMP-1. Our data suggest that in diseased brain tissue, the ability of astrocytes to counteract the destructive effects of MMP through expression of TIMP-1 is diminished by chronic activation. Our studies reveal new opportunities for repair-based therapeutic strategies in HAD.

Original languageEnglish (US)
Pages (from-to)47-56
Number of pages10
JournalGlia
Volume44
Issue number1
DOIs
StatePublished - Oct 1 2003

Fingerprint

AIDS Dementia Complex
Tissue Inhibitor of Metalloproteinase-1
Astrocytes
HIV-1
Dementia
Matrix Metalloproteinases
Tissue Inhibitor of Metalloproteinases
Interleukin-1
Brain
Inflammation
Aptitude
Poisons
Brain Diseases
Phagocytes
Blood-Brain Barrier
Extracellular Matrix
Up-Regulation

Keywords

  • Astrogliosis
  • HIV-1
  • Matrix metalloproteinase
  • Neurodegenerative disorders

ASJC Scopus subject areas

  • Neurology
  • Cellular and Molecular Neuroscience

Cite this

Suryadevara, R., Holter, S., Borgmann, K., Persidsky, R., Labenz-Zink, C., Persidsky, Y., ... Ghorpade, A. (2003). Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: Links to HIV-1 dementia. Glia, 44(1), 47-56. https://doi.org/10.1002/glia.10266

Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes : Links to HIV-1 dementia. / Suryadevara, Radhika; Holter, Spring; Borgmann, Kathleen; Persidsky, Raisa; Labenz-Zink, Christine; Persidsky, Yuri; Gendelman, Howard Eliot; Wu, Li; Ghorpade, Anuja.

In: Glia, Vol. 44, No. 1, 01.10.2003, p. 47-56.

Research output: Contribution to journalArticle

Suryadevara, R, Holter, S, Borgmann, K, Persidsky, R, Labenz-Zink, C, Persidsky, Y, Gendelman, HE, Wu, L & Ghorpade, A 2003, 'Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: Links to HIV-1 dementia', Glia, vol. 44, no. 1, pp. 47-56. https://doi.org/10.1002/glia.10266
Suryadevara R, Holter S, Borgmann K, Persidsky R, Labenz-Zink C, Persidsky Y et al. Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: Links to HIV-1 dementia. Glia. 2003 Oct 1;44(1):47-56. https://doi.org/10.1002/glia.10266
Suryadevara, Radhika ; Holter, Spring ; Borgmann, Kathleen ; Persidsky, Raisa ; Labenz-Zink, Christine ; Persidsky, Yuri ; Gendelman, Howard Eliot ; Wu, Li ; Ghorpade, Anuja. / Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes : Links to HIV-1 dementia. In: Glia. 2003 ; Vol. 44, No. 1. pp. 47-56.
@article{cb4eabcd373d4048905db5af6a5a030d,
title = "Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: Links to HIV-1 dementia",
abstract = "The neuropathogenesis of HIV-1-associated dementia (HAD) revolves around the secretion of toxic molecules from infected and immune-competent mononuclear phagocytes. Astrocyte activation occurs in parallel but limited insights are available for its role in neurotoxicity and cognitive dysfunction. One means in which astrocytes may affect disease is through their production of tissue inhibitors of metalloproteinases (TIMPs). TIMPs are regulators of matrix metalloproteinases, enzymes that affect blood-brain barrier integrity through altering the extracellular matrix. We hypothesized that in response to injury and inflammation in HAD, astrocytes regulate the production of TIMP-1, the inducible type of TIMP that is important in inflammation. To address astrocyte-mediated TIMP-1 regulation in HAD, we evaluated the responses of primary human to IL-1β and HIV-1. TIMP-1 levels in plasma, CSF, and brain tissue of control, HIV-1 infected patients without cognitive impairment, and HAD patients were also studied. Our data show that an upregulation of TIMP-1 results from astrocytes acutely activated with IL-1β. In contrast, CSF and brain tissue samples from HAD patients showed reduced TIMP-1 levels compared to seronegative controls. MMP-2 levels in brains showed the opposite. Consistent with this, prolonged activation of astrocytes led to a reduction in TIMP-1 and MMP-2, but a sustained elevation in MMP-1. Our data suggest that in diseased brain tissue, the ability of astrocytes to counteract the destructive effects of MMP through expression of TIMP-1 is diminished by chronic activation. Our studies reveal new opportunities for repair-based therapeutic strategies in HAD.",
keywords = "Astrogliosis, HIV-1, Matrix metalloproteinase, Neurodegenerative disorders",
author = "Radhika Suryadevara and Spring Holter and Kathleen Borgmann and Raisa Persidsky and Christine Labenz-Zink and Yuri Persidsky and Gendelman, {Howard Eliot} and Li Wu and Anuja Ghorpade",
year = "2003",
month = "10",
day = "1",
doi = "10.1002/glia.10266",
language = "English (US)",
volume = "44",
pages = "47--56",
journal = "GLIA",
issn = "0894-1491",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes

T2 - Links to HIV-1 dementia

AU - Suryadevara, Radhika

AU - Holter, Spring

AU - Borgmann, Kathleen

AU - Persidsky, Raisa

AU - Labenz-Zink, Christine

AU - Persidsky, Yuri

AU - Gendelman, Howard Eliot

AU - Wu, Li

AU - Ghorpade, Anuja

PY - 2003/10/1

Y1 - 2003/10/1

N2 - The neuropathogenesis of HIV-1-associated dementia (HAD) revolves around the secretion of toxic molecules from infected and immune-competent mononuclear phagocytes. Astrocyte activation occurs in parallel but limited insights are available for its role in neurotoxicity and cognitive dysfunction. One means in which astrocytes may affect disease is through their production of tissue inhibitors of metalloproteinases (TIMPs). TIMPs are regulators of matrix metalloproteinases, enzymes that affect blood-brain barrier integrity through altering the extracellular matrix. We hypothesized that in response to injury and inflammation in HAD, astrocytes regulate the production of TIMP-1, the inducible type of TIMP that is important in inflammation. To address astrocyte-mediated TIMP-1 regulation in HAD, we evaluated the responses of primary human to IL-1β and HIV-1. TIMP-1 levels in plasma, CSF, and brain tissue of control, HIV-1 infected patients without cognitive impairment, and HAD patients were also studied. Our data show that an upregulation of TIMP-1 results from astrocytes acutely activated with IL-1β. In contrast, CSF and brain tissue samples from HAD patients showed reduced TIMP-1 levels compared to seronegative controls. MMP-2 levels in brains showed the opposite. Consistent with this, prolonged activation of astrocytes led to a reduction in TIMP-1 and MMP-2, but a sustained elevation in MMP-1. Our data suggest that in diseased brain tissue, the ability of astrocytes to counteract the destructive effects of MMP through expression of TIMP-1 is diminished by chronic activation. Our studies reveal new opportunities for repair-based therapeutic strategies in HAD.

AB - The neuropathogenesis of HIV-1-associated dementia (HAD) revolves around the secretion of toxic molecules from infected and immune-competent mononuclear phagocytes. Astrocyte activation occurs in parallel but limited insights are available for its role in neurotoxicity and cognitive dysfunction. One means in which astrocytes may affect disease is through their production of tissue inhibitors of metalloproteinases (TIMPs). TIMPs are regulators of matrix metalloproteinases, enzymes that affect blood-brain barrier integrity through altering the extracellular matrix. We hypothesized that in response to injury and inflammation in HAD, astrocytes regulate the production of TIMP-1, the inducible type of TIMP that is important in inflammation. To address astrocyte-mediated TIMP-1 regulation in HAD, we evaluated the responses of primary human to IL-1β and HIV-1. TIMP-1 levels in plasma, CSF, and brain tissue of control, HIV-1 infected patients without cognitive impairment, and HAD patients were also studied. Our data show that an upregulation of TIMP-1 results from astrocytes acutely activated with IL-1β. In contrast, CSF and brain tissue samples from HAD patients showed reduced TIMP-1 levels compared to seronegative controls. MMP-2 levels in brains showed the opposite. Consistent with this, prolonged activation of astrocytes led to a reduction in TIMP-1 and MMP-2, but a sustained elevation in MMP-1. Our data suggest that in diseased brain tissue, the ability of astrocytes to counteract the destructive effects of MMP through expression of TIMP-1 is diminished by chronic activation. Our studies reveal new opportunities for repair-based therapeutic strategies in HAD.

KW - Astrogliosis

KW - HIV-1

KW - Matrix metalloproteinase

KW - Neurodegenerative disorders

UR - http://www.scopus.com/inward/record.url?scp=0141616458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141616458&partnerID=8YFLogxK

U2 - 10.1002/glia.10266

DO - 10.1002/glia.10266

M3 - Article

C2 - 12951656

AN - SCOPUS:0141616458

VL - 44

SP - 47

EP - 56

JO - GLIA

JF - GLIA

SN - 0894-1491

IS - 1

ER -